ヒューマンMX2は,HIV-1感染のインターフェロン誘発のポストエントリー阻害剤です
Caroline Goujon1, Olivier Moncorgé, Hélène Bauby
1Department of Infectious Diseases, King's College London, London SE1 9RT, UK.
Nature
|September 20, 2013
まとめ
ミクソウイルス耐性2 (MX2) タンパク質は,ウイルスのDNA統合を阻害することによって,ヒト免疫不全ウイルス1型 (HIV-1) 感染を強力に抑制します. このインターフェロン刺激因子は,HIV/AIDSの新たな治療標的となる可能性がある.
科学分野:
- ウイルス学 ウイルス学 ウイルス学
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
背景:
- 動物細胞は,ウイルスの複製を制限する天生的免疫を持っています.
- ヒト免疫不全ウイルス1型 (HIV-1) は,様々な制限因子とインターフェロン刺激遺伝子によって抑制されます.
- ミキソウイルス耐性2 (MX2) は,抗ウイルス性を持つインターフェロン誘発タンパク質です.
研究 の 目的:
- HIV-1複製を阻害する新しい宿主因子を特定し,特徴づけること.
- インターフェロン媒介の抗HIV-1活性のエフェクタとしてMX2の役割を定義する.
- MX2がHIV-1感染を制限するメカニズムを解明する.
主な方法:
- エクトピック発現と遺伝子静止実験が採用されました.
- HIV-1菌株および他のレトロウイルスに対する抑制が評価されました.
- MX2感受性におけるウイルスのガグタンパク質のカプシド領域の役割が調査されました.
- 核の蓄積と染色体統合を含むウイルスのDNA複製のエントリー後のステップを分析した.
主要な成果:
- MX2は,HIV-1感染の強力な阻害剤として特定され,すべての試験株に対して有効でした.
- MX2は,侵入後の遅いステップをターゲットにすることで感染を抑制し,ウイルスDNAの核蓄積と統合を阻害します.
- MX2に対する感受性は,HIV-1ガグタンパク質のカプシド領域によって決定される.
- MX2は,類人猿の免疫不全ウイルスや他のレトロウイルスに対する活性が低下または全くなかったことを示し,MX1.1とは異なり,インフルエンザウイルスに対して無効であった.
結論:
- MX2は,HIV-1感染に対する重要な細胞自律的制限因子です.
- MX2は,HIV-1に対するインターフェロン誘発型1型耐性の重要な効果因子として作用する.
- MX2をターゲットにすることで,HIV/AIDS治療の新たな治療戦略を提供することができる.
関連する概念動画
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.


